Ironwood Pharmaceuticals IRWD Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's software and technology licenses, net?
- Ironwood Pharmaceuticals (IRWD) reported software and technology licenses, net of $4.14M in Q1 2026.
- How has Ironwood Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Ironwood Pharmaceuticals's software and technology licenses, net decreased by 25.3% year-over-year, from $5.54M to $4.14M.
- What is the long-term trend for Ironwood Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's software and technology licenses, net has grown at a 36.7% compound annual growth rate (CAGR), from $943K to $4.5M.